Researchers identify critical marker of response to gemcitabine in pancreatic cancer

A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson University.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news163331753.html">Researchers identify critical marker of response to gemcitabine in pancreatic cancer</a></p> <p>A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in <i>Cancer Research</i>, published by researchers at Thomas Jefferson University.</p>